Hikma Pharmaceutical | HIK - Le Chiffre D'Affaires De Vente

Prix De L'Action
1,258.50
Variation Quotidienne
-4.50 -0.36%
Mensuellement
0.76%
Annuel
-35.89%
Q1 Prévisions
1,233.89




Ventes Changement Date
Almirall EUR 547.63M 12.83M 2025-12
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Autolus Therapeutics Ltd USD 22.61M 1.71M 2025-09
Bayer EUR 11.44B 1.78B 2025-12
Fresenius EUR 5.88B 400M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Orion EUR 695.3M 272.1M 2025-12
Recordati EUR 662M 37.65M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
UCB EUR 4.25B 764M 2025-12